No profile data available.
InVitro International, Inc. (IVRO) is a healthcare company in the biological analysis equipment industry, based in Placentia, United States.
It reported revenue of $1.10 million for fiscal year 1996, about flat from fiscal year 1995, and net income of -$1.90 million. In Q2 2026 (the quarter ended March 31, 2026) revenue was $206,840, up 5.3% from a year before. United States was its largest region in fiscal year 2024, with 63% of revenue. Its market capitalization was $1.34 million as of October 8, 2026.
Figures from company filings and market data; latest fiscal year ended September 30, 1996; market data as of October 8, 2026.
InVitro International, Inc. develops test kits for non-animal testing applications in the United States and internationally.
InVitro International reported $1.10 million in revenue for fiscal year 1996, about flat from $1.10 million in fiscal year 1995. In Q2 2026 revenue was $206,840.
United States: 63% of revenue by region in fiscal year 2024, followed by Other Countries (37%).
$1.34 million as of October 8, 2026.
Listed companies of a similar size in the same industry (biological analysis equipment) include Advanced Biomed Inc. (ADVB), iSpecimen Inc. (ISPC), International Stem Cell Corporation (ISCO), Telesis Bio, Inc. (TBIO).